Abstract
Hypertension management remains suboptimal globally, with treatment inertia being identified as one of the main barriers to achieving blood pressure (BP) control. Simpler approaches to achieve target BP levels are needed. The QUARTET study (Quadruple Ultra-Low-Dose Treatment for Hypertension) demonstrated that a single-pill combination of 4 BP-lowering medications at ultra-low (quarter) doses is more effective in reducing and maintaining lower unattended office BP than initial monotherapy with uptitration if needed. This Research Letter summarizes key, prespecified, secondary outcomes from 24-hour ambulatory BP monitoring (ABPM) performed at baseline and at 52 weeks of extended follow-up.
Original language | English |
---|---|
Pages (from-to) | 375-377 |
Number of pages | 3 |
Journal | Circulation |
Volume | 148 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2023 |